SeleXel is a biotechnology company whose mission is to develop efficient therapeutic solutions in Oncology using a very innovative technology: RNA interference. This natural biological mechanism allows to very specifically impair the synthesis of proteins required for the development of a cancer. SeleXel concentrates its initial efforts on the development of drugs treating prostate cancers that became resistant to conventional hormonal treatments. The company develops a portfolio of siRNAs blocking cancer spreading (metastasis), and restoring the ability of the immune system to eliminate the tumor.
| Website | http://www.selexel.com |
| Revenue | $6 million |
| Employees | View employees |
| Founded | 2006 |
| Address | 7 Rue Guy Môquet, Villejuif, Ile-de-France 94801, FR |
| Industry | Biotechnology, Business Services General, Business Services, Science and Engineering |
| Competitors | Infosphere Inc., Analytica, Quantum Leap Technologies (QLT), Optimo Solutions, Vertex Innovations, Predictive Dynamics Corp, COREINSIGHTSResearch & Marketing Strategy, Datawise Solutions Inc - Cabling & Electrical Branch, Analytic Edge, Clarity Systems +10 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular SeleXel employee's phone or email?
SeleXel Questions
The SeleXel annual revenue was $6 million in 2026.
SeleXel is based in Villejuif, Ile-de-France.
The NAICS codes for SeleXel are [54, 54171, 5417, 541713, 541].
The SIC codes for SeleXel are [87, 873].
